Post by
Skater on Nov 15, 2017 10:08am
ACB
Well I always thought at CanniMed's meager valuation this day would come, just thought it would be Aphria on the bid side, or Canopy being hostile just because they can. I expect CanniMed will reject the offer, claiming its undervalued. Will be a few rounds with Aurora, best case is someone else sees CMED in play and takes a run at them, whether a MJ competitor or big pharama (or alcohol or tobacco). $24 is low, but is Cannimed really worth more than $1 billion? Doubt it. Deal will be done in the low $40's and thats all she wrote IMO>
GLTA
Skater
Comment by
dogger05 on Nov 15, 2017 10:19am
Is canopy really worth 3.5 billion....Cmed should be worth 1 billlion minimum if cgc is worth that much
Comment by
Skater on Nov 15, 2017 10:34am
Also should be noted that CanniMed had >$3/share in working cap at the end of July, likely still holding the majority of that, takes ACB's offer down to $21. I suggest (or is it hope?) that $24 is just the opening volley.... Skater
Comment by
dogger05 on Nov 15, 2017 10:37am
This is just the beginning. No way acb gets to steal this